Alzheimer’s drug cited as Medicare premium jumps by $21.60
New review article outlines potential of SARS-CoV-2 genetic sequencing in patient care
12 November 2021Novel surgical device can potentially improve outcomes of coronary bypass grafting that uses leg veins
13 November 2021Alzheimer’s drug cited as Medicare premium jumps by $21.60
Medicare’s “Part B” outpatient premium will jump by $21.60 next year, one of the largest increases ever. Officials said Friday a new Alzheimer’s drug is responsible for about half of that.
